Salvage Therapy with Ceftolozane-Tazobactam for Multidrug-Resistant Pseudomonas aeruginosa Infections

Author:

Castón Juan José12,De la Torre Álvaro3,Ruiz-Camps Isabel4,Sorlí María Luisa5,Torres Vicente6,Torre-Cisneros Julián127

Affiliation:

1. Clinical Unit of Infectious Diseases, Hospital Universitario Reina Sofía-Instituto Maimónides de Investigación Biomédica (IMIBIC), Córdoba, Spain

2. Spanish Network for the Research in Infectious Diseases (REIPI RD12/2015), Instituto de Salud Carlos III, Madrid, Spain

3. Service of Anesthesiology and Reanimation, Hospital de Jaen, Jaen, Spain

4. Department of Infectious Diseases, Hospital Universitario Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain

5. Department of Infectious Diseases, Hospital del Mar, Barcelona, Spain

6. Service of Anesthesia and Reanimation, Hospital Universitario Son Espases, Palma de Mallorca, Spain

7. Universidad de Córdoba, Córdoba, Spain

Abstract

ABSTRACT Infections caused by multidrug-resistant Pseudomonas aeruginosa (MDRPA) present a major problem for therapeutic management. We report here our experience with 12 patients with a severe MDRPA infection (6 of which were pneumonia) who received salvage therapy with ceftolozane-tazobactam after inappropriate empirical treatment and/or suboptimal targeted treatment. Although 10 of the 12 patients (83.3%) experienced septic shock, only 3 patients (25%) died during the follow-up period. Microbiological cure in 7 patients (58.3%) was observed.

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3